Laying siege to beta-amyloid, the key protein in Alzheimer's disease

This is the first time that a method allows scientists to monitor aggregation while simultaneously detect a structural pattern responsible for the toxicity of beta-amyloid aggregation.The researchers state that these studies are a step towards finding a therapeutic target for a disease which, to date, has no treatment.